CHANGES IN THE HAEMOSTASIS SYSTEM UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS IN COMBINATION WITH OBESITY USING ADEMETHIONINE, ARGININE GLUTAMATE AND ROSUVASTATIN

  • N. R. Matkovska Ivano-Frankivsk national medical university
Keywords: alcoholic liver disease; liver cirrhosis; obesity; haemostasis.

Abstract

Introduction. The urgency of the problem of liver cirrhosis (LC) is caused by the increase in morbidity, prevalence, life-threatening complications, disability and increasing mortality of able-bodied population. The aim of the study was to examine the effect of complex treatment with ademethionine, arginine glutamate and rosuvastatin on changes in the haemostasis systemin patients with alcoholic liver cirrhosis (ALC) in combination with obesity. Research methods. The study included 105 patients diagnosed with ALC in combination with obesity. The assessment of the effectiveness of a three-month treatment regimen with ademethionine, arginine glutamate and rosuvastatin in obese patients with alcoholic liver cirrhosis (ALC) included indicators of synthetic liver function and hemostasis (total protein, albumin, fibrinogen, platelet count, factor Von Willebrand factor, activated partial thromboplastin time (APTT), thrombin time (TT), international normalized ratio (INR), prothrombin index (PI), D-dimer, tissue plasminogen activator (tPA), 1 plasminogen activator (PAI-1), tPA/PAI-1 index, asymmetric dimethylarginine (ADMA)), as well as liver cirrhosis severity (Child-Pugh score) and 3-month MELD mortality score. Results. Decreased levels of total protein, albumin, fibrinogen, PI, platelet count and increased levels of Von Willebrand factor, prothrombin time (PT), APTT, TT, INR, D-dimer, tPA and PAI-1, ADMA were revealed. Such changes worsened with increasing liver cirrhosis decompensation and were accompanied by an increase in the Child-Pugh and MELD scores (P < 0.05). There was a more pronounced increase in levels of PAI-1 than tPA, that was accompanied by a decrease in tPA/PAI-1 index. A number of researchers indicate that an increase in PAI-1 levels can cause a hypercoagulable state, so its increase with a decrease in tPA/PAI-1 index in patients with ALC in combination with obesity indicates a risk of thrombogenic conditions. This is also evidenced by the increasing number of D-dimers. Therefore, the fibrinolytic/antifibrinolytic factors should be considered in the treatment of such patients to prevent LC complications. Conclusions. The inclusion of ademethionine, arginine glutamate and rosuvastatin in the treatment regimen for 3 months improved the levels of total protein, albumin, fibrinogen, PI, platelet count, Von Willebrand factor, PT, APTT, TT, INR, D-dimer, tPA and PAI-1, ADMA, which was accompanied by a decrease in Child-Pugh severity score and MELD 3-month mortality score.

Downloads

Download data is not yet available.

References

Blasi A., Calvo A., Prado V. et al. Coagulation failure in patients with acute‐on‐chronic liver failure and decompensated cirrhosis: beyond the international normalized ratio // Hepatology. – 2018. – Vol. 68, N 6. – P. 2325–2337.

Bos S., Potze W., Siddiqui M. S. et al. Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease //Thrombosis Research. – 2017. – Т. 150. – P. 41–43.

Bos S., van den Boom B., Kamphuisen P. W. et al. Haemostatic profiles are similar across all aetiologies of cirrhosis // Thrombosis and haemostasis. – 2019. – Vol. 119, N 2. – P. 246–253.

Budimir I., Gradišer M., Nikolić M. et al. Glasgow Blatchford, pre-endoscopic Rockall and AIMS65 scores show no difference in predicting rebleeding rate and mortality in variceal bleeding // Scandinavian J. of Gastroenterology. – 2016. – Vol. 51, N 11. – P. 1375–1379.

Fisher C., Patel V. C., Stoy S. H. et al. Balanced haemostasis with both hypo-and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure // J. of Critical Care. – 2018. – Vol. 43. – P. 54–60.

Hugenholtz G. C., Macrae F., Adelmeijer J. et al. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen //Journal of Thrombosis and Haemostasis. – 2016. – Vol. 14, N 5. – P. 1054–1066.

Intagliata N. M., Argo C. K., Stine J. G. et al. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference: October 6th and 7th, 2017 Rome, Italy // Thrombosis and Haemostasis. – 2018. – Vol. 118, N 8. – P. 1491.

Intagliata N. M., Davis J. P. E., Caldwell S. H. Coagulationpath ways, hemostasis, and thrombosis in liver failure //Seminars in respiratory and critical care medicine // Thieme Med. Publishers. – 2018. – Vol. 39, N 5. – P. 598–608.

Kalambokis G. N., Oikonomou A., Christou L. et al. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia // J. of Hepatology. – 2016. – Vol. 65, N 5. – P. 921–928.

Kopec A. K., Joshi N., Luyendyk J. P. Role of hemostatic factors in hepatic injury and disease: animal models de‐liver // J. of Thrombosis and Haemostasis. – 2016. – Vol. 14, N 7. – P. 1337–1349.

Potze W., Siddiqui M. S., Boyett S. L. et al. Preserved hemostatic status in patients with non-alcoholic fatty liver disease //Journal of hepatology. – 2016. – Vol. 65, N 5. – P. 980–987.

Potze W., Siddiqui M. S., Sanyal A. J. Vascular disease in patients with nonalcoholic fatty liver disease // Seminars in Thrombosis and Hemostasis. – Thieme Medical Publishers. – 2015. – Vol. 41, N 5. – P. 488–493.

Stine J. G., Niccum B. A., Zimmet A. N. et al. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis // Clin. Transl. Gastroenterol. – 2018. – Vol. 9, N 3. – P. 140–147.

Vinholt P. J., Hvas A. M., Nielsen C. et al. Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis // Platelets. – 2018. – Vol. 29, N 5. – P. 520–527.

Yilmaz V. T., Dincer D., Avci A. B. et al. Significant association between serum levels of von Willebrand factor (vWF) antigen with stages of cirrhosis // The Eur. J. of Med. – 2015. – Vol. 47, N 1. – P. 21.


Abstract views: 27
PDF Downloads: 61
Published
2020-03-30
How to Cite
Matkovska, N. R. (2020). CHANGES IN THE HAEMOSTASIS SYSTEM UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS IN COMBINATION WITH OBESITY USING ADEMETHIONINE, ARGININE GLUTAMATE AND ROSUVASTATIN. Likars’ka Sprava, (1-2), 42-49. https://doi.org/10.31640/JVD.1-2.2020(6)
Section
Guide lines for the practitioner